Skip to content
The Policy VaultThe Policy Vault

Nexletol (bempedoic acid)Medica

Established cardiovascular disease

Initial criteria

  • age ≥ 18 years
  • Patient has had ONE of the following: previous myocardial infarction or a history of an acute coronary syndrome; OR angina (stable or unstable); OR a past history of stroke or transient ischemic attack; OR coronary artery disease; OR peripheral arterial disease; OR patient has undergone a coronary or other arterial revascularization procedure (e.g., coronary artery bypass graft surgery, percutaneous coronary intervention, angioplasty, or coronary stent procedures)
  • Patient meets ONE of the following: Patient has tried one high-intensity statin therapy (atorvastatin ≥ 40 mg daily or rosuvastatin ≥ 20 mg daily as a single entity or combination product)

Reauthorization criteria

  • Currently receiving therapy with Nexletol

Approval duration

1 year